Affiliate disclosure: As an Amazon Associate, this site earns from qualifying purchases linked in this article.
Perimenopause often brings fluctuations in mood, including irritability, low mood, and anxiety, which can significantly affect quality of life. Many women explore dietary supplements such as curcumin, a polyphenol from turmeric, for potential support during this transition.
The evidence base for curcumin’s effects on mood in perimenopause is moderate. Clinical guidelines from the World Federation of Societies of Biological Psychiatry and the Canadian Network for Mood and Anxiety Treatments have evaluated nutraceuticals for psychiatric disorders, including curcumin [1]. A few randomized controlled trials have examined curcumin in postmenopausal and postpartum populations, providing indirect insights [2][3][4]. However, no large trials have specifically targeted perimenopausal mood symptoms, so conclusions remain preliminary.
Clinical Guidelines on Nutraceuticals for Mood Disorders
The WFSBP and CANMAT taskforce published consensus guidelines on the use of nutraceuticals and phytoceuticals for psychiatric disorders, aiming to provide clinicians with evidence-based recommendations [1]. The guideline panel reviewed available data on curcumin for depressive disorders and categorized it as a nutraceutical with emerging supportive evidence, suggesting it may be considered as an adjunctive option in certain clinical contexts.
The guidelines emphasize that the quality of evidence varies, with many studies being small or heterogeneous, and they recommend that any use be individualized and monitored by a healthcare professional. They also note that curcumin should not replace conventional treatments for moderate to severe depression.
Curcumin and Menopausal Symptoms in Postmenopausal Women
A triple-blind, randomized controlled trial investigated a combination of curcumin and vitamin E in healthy postmenopausal women, assessing changes in inflammatory-oxidative stress biomarkers and primary menopausal symptoms [2]. The intervention period lasted several months and included validated symptom scales.
The study reported improvements in several symptom domains, including vasomotor and psychosocial symptoms, though mood-specific subscales were not the primary outcome. Reductions in oxidative stress markers were observed, which the authors hypothesized could contribute to symptom relief. These findings suggest a possible benefit for overall menopausal well-being, but direct evidence for perimenopausal mood changes is lacking.
Postpartum Depression Trial Findings
A double-blind, placebo-controlled trial evaluated curcumin supplementation in primiparous women experiencing postpartum depression and anxiety [3]. Participants received a standardized curcumin extract for eight weeks, and depressive and anxiety symptoms were measured using validated rating scales.
The trial found statistically significant reductions in both depression and anxiety scores compared with placebo, with a favorable safety profile. While postpartum depression differs from perimenopausal mood disturbances, the hormonal fluctuations in both periods share some neurobiological pathways, making these results relevant for hypothesis generation.
Fatigue and Musculoskeletal Health in Postmenopause
Another double-blind RCT examined the effect of curcumin on fatigue and musculoskeletal health in postmenopausal women [4]. Fatigue is a common complaint during menopause and often coexists with low mood.
The study reported improvements in fatigue severity and some musculoskeletal discomfort measures after curcumin supplementation. Although mood was not a primary endpoint, reductions in fatigue may indirectly support better mood and daily functioning. The trial adds to the limited data on curcumin’s role in menopause-related quality of life.
Mechanistic Considerations and Evidence Gaps
Curcumin’s potential mood-related effects are often attributed to its anti-inflammatory, antioxidant, and neurotrophic properties, which may modulate neurotransmitter systems and reduce neuroinflammation implicated in depression. However, the clinical trials cited above did not directly measure these mechanisms in perimenopausal women.
Key evidence gaps include the absence of large, perimenopause-specific trials, variability in curcumin formulations and doses across studies, and limited long-term safety data. Current evidence is best described as preliminary and hypothesis-generating rather than definitive.
Practical Considerations and Safety
Curcumin supplements differ widely in bioavailability; formulations enhanced with piperine, phospholipids, or nanoparticle technology are designed to increase absorption. The trials referenced used specific proprietary extracts, and the optimal dose for mood support during perimenopause has not been established.
Common side effects include mild gastrointestinal upset. Curcumin may interact with anticoagulants, antiplatelet drugs, chemotherapy agents, and medications metabolized by cytochrome P450 enzymes. Women with gallbladder disease, iron deficiency, or those who are pregnant or breastfeeding should exercise caution. Consultation with a healthcare provider before starting any supplement is essential, especially if you are taking prescription medications or have a diagnosed mood disorder.
References
- Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2022
- Clinical Efficacy of Curcumin and Vitamin E on Inflammatory-Oxidative Stress Biomarkers and Primary Symptoms of Menopause in Healthy Postmenopausal Women: A Triple-Blind Randomized Controlled Trial. Journal of nutrition and metabolism, 2022
- The effect of curcumin on postpartum depression and anxiety in primiparous women: a double-blind randomized placebo-controlled clinical trial. BMC complementary medicine and therapies, 2025
- Effect of curcumin on fatigue and musculoskeletal health in postmenopausal women: a double-blind randomised controlled trial. BMJ open, 2025
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
